Riskpilot← Back to searchSign inGet full accessAcouSort AB
ABActiveOrg 5568241037Medicon VillageResearch and experimental development on natural sciences and engineering · NACE 7210Est. 201016 employees
Revenue 2024
SEK 4,8M
-13% vs 2023
EBITDA margin
-308.0%
-7% vs 2023
Equity ratio
76.0%
Financial strength
Net profit 2024
SEK -15,8M
-14% vs 2023
| Revenue | SEK 4,8M | -13% |
| EBITDA | SEK -14,7M | -7% |
| Net profit | SEK -15,8M | -14% |
| Total assets | SEK 16,1M | -58% |
| Equity | SEK 12,2M | -57% |
| Employees | 16 | — |
Legal name
AcouSort AB
Org number
5568241037
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 november 2010
Share capital
SEK 1 493 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Freltoft, Torsten Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla och försälja biotekniska metoder och utrustning för separation av celler och annan därmed förenlig verksamhet.
Address
Medicon Village
Email
info@acousort.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 482 | 1 074 | 1 856 | 4 928 | 3 007 | 4 963 | 5 496 | 4 760 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −295 | −643 | −6 072 | −8 925 | −9 599 | −7 715 | −11 516 | −12 556 | −13 734 | −14 663 |
| Depreciation & amort. | −0 | −0 | −0 | −46 | −46 | −98 | −638 | −921 | −783 | −233 |
| EBIT | −295 | −643 | −6 072 | −8 971 | −9 645 | −7 813 | −12 154 | −13 477 | −14 517 | −14 896 |
| Net financials | −3 | −187 | — | 11 | −37 | −406 | −46 | 554 | 565 | −2 224 |
| Profit before tax | −279 | −830 | −6 072 | −8 960 | −9 657 | −7 978 | −12 200 | −12 908 | −13 952 | −15 848 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −279 | −830 | −6 072 | −8 960 | −9 657 | −7 978 | −12 200 | −12 908 | −13 952 | −15 848 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 261 | 12 039 | 4 947 | 17 439 | 8 035 | 13 171 | 36 560 | 42 656 | 38 619 | 16 096 |
| Equity | 79 | 9 955 | 3 883 | 15 579 | 5 922 | 9 592 | 33 022 | 20 114 | 28 241 | 12 236 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 182 | 2 084 | 1 064 | 1 860 | 2 113 | 3 579 | 3 537 | 22 542 | 10 378 | 3 861 |
| Total debt | 182 | 2 084 | 1 064 | 1 860 | 2 113 | 3 579 | 3 537 | 22 542 | 10 378 | 3 861 |
EBITDA margin
-308.0%
This company
15.8%
Market median
-2049% vs market
20152024
Equity ratio
76.0%
This company
38.2%
Market median
+99% vs market
20152024
Return on equity
-129.5%
This company
18.4%
Market median
-804% vs market
20152024
Net profit margin
-332.9%
This company
8.1%
Market median
-4210% vs market
20152024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20152024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MN Chief Auditor | Chief Auditor | 2022 | — | — |
LM Chief Auditor | Chief Auditor | 2022 | — | — |
TF Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AO Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AcouSort AB (this company)
Acousort IncACOUSORT INCBoard members of AcouSort AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Nilsson | Chief Auditor | 0 companies |
| Lisa Maria Albertsson | Chief Auditor | 0 companies |
| Torsten Freltoft | Chief Executive Officer | 0 companies |
| Anders Ola Bjärehäll | Chief Auditor | 0 companies |
| Per Richard Valdemar Sundkvist | Board of Directors | 0 companies |
| Matts Ole Kristian Enkvist | Board of Directors | 0 companies |
| Anders Stefan Blomsterberg | Chairman | 0 companies |
| Stefan Scheding | Board of Directors | 0 companies |
| Sven Martin Linde | Chairman | 0 companies |
| Martin Lechner | Chairman | 0 companies |
| Lars Thomas Laurell | Board of Directors | 0 companies |
| Katherine Joanne Flagg | Board of Directors | 0 companies |